Axion BioSystems, a leading life sciences tools company focused on advanced live-cell assay systems, announces the acquisition of the Netherlands-based CytoSMART Technologies—an innovator in kinetic live-cell imaging analysis. The collaboration positions Axion for significant expansion in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery.
Latest Aithority Insights : Alteryx Launches Updated Partner Program
Axion BioSystems acquires live-cell imaging innovator, CytoSMART Technologies, for expansion in the fields of stem cell research, immuno-oncology, cell-based therapies, and drug discovery @AxionBio1 @CytoSMART #StemCells #ImmunoOncology
“Since Axion BioSystems’ inception, our focus has been on developing user-centric products that accelerate scientific discovery, with the specific goal of building innovative systems that monitor cellular activity without disturbing the underlying biology. The Maestro, our flagship bioelectronic assay (BEA) platform, has transformed neurological disease research over the past 14 years. Likewise, our most recent addition to the BEA portfolio is doing the same in groundbreaking fields like immunotherapy,” said Tom O’Brien, President & CEO of Axion BioSystems. “In CytoSMART, we found a company with technology complementary to our own, as well as a partner with the same fundamental objective—to provide customers with high-quality instruments and powerful software that rapidly advance live-cell research and cell therapy development. We welcome the entire CytoSMART team, and we are excited to add their expertise to our own.”
Browse The Complete News About Aithority: Wix Releases Inaugural Environmental, Social and Governance (ESG) Report
Noninvasively studying the real-time biology of live cells allows scientists to obtain a more complete understanding of the complex processes underpinning health and disease. In their respective arenas, both Axion and CytoSMART have focused on the development of next-generation analysis tools for use in pharmaceutical, academic, and biotechnology research. Along with Axion’s recent acquisition of UK-based printed electronics manufacturer M-Solv Manufacturing Limited, this latest product portfolio expands the company’s offerings and opportunities in a rapidly growing life sciences tools market.
According to Joffry Maltha, CEO of CytoSMART, the mutually beneficial partnership is a natural fit. “Axion’s overall mission and corporate culture align with our efforts to provide scientists around the world with high-quality, easy-to-use products to advance their research goals. With Axion’s resources and experience, we look forward to accelerating our market growth and product innovation.”
Read More About Aithority News : ColdQuanta Expands Executive Team with Appointment of Photonics and Software Technologists
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.